GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75F40118F01002BIOPHARMA SERVICES USA

Overview

Award facts

Net obligations
$2.88M
$2,877,830of $2.88M potential value
Outlays (paid to date)
$2.10M
$2.10M paid of $2.88M obligated$2,104,565
Period of performance
Sep 13, 2018 to Jul 24, 2024
Ended
Modifications
12
Latest action Feb 29, 2024
Contract type
Delivery order
PIID 75F40118F01002

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::CL::IGF - NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS

Dates and value

Award date
Signed on Sep 13, 2018
Potential end of performance
Jul 23, 2024
Current value
$2,877,830Base and exercised options
Potential value (if all options are exercised)
$2,877,830
Parent contract vehicle
HHSF223201610004I (IDC, single award) — 4 orders recorded under it

Obligations by fiscal year of action

  • FY2023: $69,565
  • FY2022: $19,560
  • FY2020: $999,305
  • FY2019: $553,188
  • FY2018: $1,236,212

Total across 5 fiscal years: $2,877,830

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 29, 2024. View on USAspending · Recipient on SAM.gov

Recipient

NameBIOPHARMA SERVICES USA
LocationCOLUMBIA, MO
UEIDRLXCANKKNN6
CAGE code7G0A9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBIOPHARMA SERVICES USA

Business types and certifications

Foreign-ownedFor-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Columbia, Boone County, Missouri 65201-6569
Congressional district (place of performance)
MO-04As reported at the time of the action

Classification and competition

Classification

NAICS
541690OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
Product or service (PSC)
B528SPECIAL STUDIES/ANALYSIS- REGULATORY (service)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Not reported
Contract pricing
Firm fixed priceJ

Solicitation and notices

Solicitation ID
FDASOL1146520(as reported)

Contract details

Subcontracting plan
Commercial subcontract planG
Major program
In vivo study of generic drug products in human subjects
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 13, 2018Base obligation at award: $1,236,212
Latest action
Feb 29, 2024 — Other administrative actionModification P00012; administrative: no change in scope or value
Latest substantive action
Sep 24, 2021 — Supplemental agreement (within scope)Modification P00006
Latest funding action
Apr 27, 2023 — Funding onlyModification P00011; obligation change +$69,565; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action8
  • Supplemental agreement (within scope)2
  • Funding only1
  • Option exercised1
13 actions recorded, Sep 13, 2018 to Feb 29, 2024; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
13

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2019/2019-0600-000
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.3: Other goods and services from Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression